Shire PLC (NASDAQ:SHPG)

162.40
Delayed Data
As of Jun 21
 +1.79 / +1.11%
Today’s Change
123.73
Today|||52-Week Range
177.51
+4.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$51.3B

Company Description

Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol. Shire was founded in 1986 and is headquartered in Dublin, Ireland.

Contact Information

Shire Plc
Miesian Plaza
Dublin Dublin 2
P:(531) 609-6000
Investor Relations:
441256894160

Employees

Shareholders

Mutual fund holders5.98%
Other institutional12.68%
Individual stakeholders--

Top Executives

Flemming OrnskovChief Executive Officer & Executive Director
Thomas J. W. DittrichChief Financial Officer & Director
Howard MayerChief Medical Officer
Matthew WalkerHead-Technical Operations
Andreas Eugen BuschChief Scientific Officer